Completion mastectomy after breast conserving surgery

Breast

Volumn 17, Issue 2, 2008, Pages 199-204

  O'Donnell, M E ^a   Salem, A ^a   Badger, S A ^a   Sharif, M A ^a   Lioe, T ^a   Spence, R A J ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Breast; Cancer; Completion mastectomy; Conserving surgery; Predictors of survival

Indexed keywords

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TISSUE SECTION; TREATMENT INDICATION; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 41549135168     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.10.001     Document Type: Article

References (35)

1. Fitzpatrick D, Gavin A, Donnelly D. Cancer trends in Northern Ireland 1993-2003. Northern Ireland Cancer Registry July 2006 〈www.qub.ac.uk/nicr〉. Department of Epidemiology and Public Health, Queen's University of Belfast, Mulhouse Building, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland.
2. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
3. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
4. Walsh P.M., McCarron P., Middleton R.J., Comber H., Gavin A.T., and Murray L. Influence of mammographic screening on trends in breast-conserving surgery in Ireland. Eur J Cancer Prev 15 (2006) 138-148
5. Neri A., Marrelli D., Rossi S., De Stefano A., Mariani F., De Marco G., et al. Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence. World J Surg 31 (2007) 36-45
6. Winchester D.P., and Cox J.D. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology. CA Cancer J Clin 48 (1998) 83-107
7. Scottish Intercollegiate Guidelines Network (SIGN). Management of breast cancer in women. A national clinical guideline. Edinburgh, Scotland: Scottish Intercollegiate Guidelines Network (SIGN), SIGN Publication No. 84, Decemeber 2005. 50pp.
8. Dillon M.F., Hill A.D.K., Quinn C.M., McDermott E.W., and O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 13 (2006) 333-339
9. The Royal College of Pathologists. NHS cancer screening programmes. Pathology reporting of breast disease. NHS BSP Publication No. 58, 2005. 〈http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58-high-resolution.pdf〉.
10. Taghian A., Mohiuddin M., Jagsi R., Golberg S., Ceiley E., and Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241 (2005) 629-639
11. Neuschatz A.C., DiPetrillo T., Steinhoff M., Safali H., Yunes M., Landa M., et al. The value of breast lumpectomy margin assessment as a predictor of residual tumour burden in ductal carcinoma in situ of the breast. Cancer 94 (2002) 1917-1924
12. Mullenix P.S., Cuadrado D.G., Steele S.R., Martin M.J., See C.S., Beitler A.L., et al. Secondary operations are frequently required to complete the surgical phase of therapy in the era of breast conservation and sentinel lymph node biopsy. Am J Surg 187 (2004) 643-646
13. Owen J.R., Ashton A., Bliss J.M., Homewood J., Harper C., Hanson J., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
14. McCloskey S.A., Botnick L.E., Rose C.M., Malcolm A.W., Ozohan M.L., Mena R., et al. Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting. Breast J 12 (2006) 138-144
15. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
16. Kini V.R., Vicini F.A., Frazier R., Victor S.J., Wimbish K., and Martinez A.A. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 43 (1999) 341-346
17. Recht A., Silen W., Schnitt S.J., Connolly J.L., Gelman R.S., Rose M.A., et al. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys 15 (1988) 255-261
18. Fowble B., Solin L.J., Schultz D.J., Rubenstein J., and Goodman R.L. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19 (1990) 833-842
19. Luu H.H., Otis C.N., Reed Jr. W.P., Garb J.L., and Frank J.L. The unsatisfactory margin in breast cancer surgery. Am J Surg 178 (1999) 362-366
20. Tartter P.I., Bleiweiss I.J., and Levchenko S. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg 185 (1997) 268-273
21. Freedman G., Fowble B., Hanlon A., Nicolaou N., Fein D., Hoffman J., et al. Patients with early stage invasive cancer with close or positive margins treated with conserving surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiol Oncol Biol Physics 44 (1999) 1005-1015
22. Taghian A., Mohiuddin M., Jagsi R., Goldberg S., Ceilley E., and Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241 (2005) 629-639
23. Park C.C., Mitsumori M., Nixon A., Recht A., Connolly J., Gelman R., et al. Outcome at 8 years after breast conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18 (2000) 1668-1675
24. Obedian E., and Haffty B.G. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 6 (2000) 28-33
25. Ratanawichitrasin A., Rybicki L.A., Steiger E., Grundfest-Broniatowski S., Hermann R.E., and Crowe J.P. Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. J Am Coll Surg 188 (1999) 17-21
26. Moore M.M., Borossa G., Imbrie J.Z., Fechner R.E., Harvey J.A., Slingluff Jr. C.L., et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231 (2000) 877-882
27. Cellini C., Hollenbeck S.T., Christos P., Martins D., Carson J., Kemper S., et al. Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol 11 (2004) 915-920
28. Wazer D.E., Schmidt-Ullrich R.K., Ruthazer R., DiPetrillo T., Boyle T., Kanski J., et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual cancer. Int J Radiat Oncol Biol Phys 45 (1999) 885-891
29. Knight III W.A., Osborne C.K., and McGuire W.L. Hormone receptors in primary and advanced breast cancer. Clin Endocrinol Metab 9 (1980) 361-368
30. Bosch A.M., Kessels A.G., Beets G.L., Rupa J.D., Koster D., van Engelshoven J.M., et al. Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur J Radiol 48 (2003) 285-292
31. Heusinger K., Lohberg C., Lux M.P., Papadopoulos T., Imhoff K., Schulz-Wendtland R., et al. Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself. Breast Cancer Res Treat 94 (2005) 17-23
32. De Roos M.A., Pijnappel R.M., Post W.J., De Vries J., Baas P.C., and Groote L.D. Correlation between imaging and pathology in ductal carcinoma in situ of the breast. World J Surg Oncol 2 (2004) 4
33. Kaufmann P., Dauphine C.E., Vargas M.P., Burla M.L., Isaac N.M., Gonzalez K.D., et al. Success of neoadjuvant chemotherapy in conversion of mastectomy to breast conservation surgery. Am Surg 72 (2006) 935-938
34. Chagpar A.B., Middleton L.P., Sahin A.A., Dempsey P., Buzdar A.U., Mirza A.N., et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 243 (2006) 257-264
35. Schott A.F., Roubidoux M.A., Helvie M.A., Hayes D.F., Kleer C.G., Newman L.A., et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 92 (2005) 231-238